ROS and Oxidative Stress in Biomedical Research from Detection Methods to Immune Regulation in the Tumor Microenvironment

Reactive oxygen species (ROS) and oxidative stress underpin diverse pathophysiological processes, with outsized roles in tumor microenvironment (TME) immune dysregulation. Widely used fluorescence probes including DCFDA, DHE and MitoSOX enable ROS tracking across cellular and organelle compartments, but mandate strict loading controls, autofluorescence correction and orthogonal validation to avoid bias from auto-oxidation, poor specificity and background artifacts.

Biologically, ROS act as a double-edged switch: low physiological levels support T cell activation, while chronic TME-elevated ROS drive T cell exhaustion, enable myeloid-derived suppressor cell immunosuppression, and create a targetable vulnerability in cancer cells that rely on NRF2-glutathione buffering to survive.

In this context, we outline core methodological safeguards for robust ROS assessment and the central role of redox imbalance in TME immune evasion. Rational redox modulation combined with immunotherapies represents a promising strategy to restore T cell effector function and curb solid tumor progression.

Table of Contents

1. Mitochondrial ROS production and electron transport chain dysfunction

2. Fluorescent probe-based detection of intracellular ROS (DCFDA assay)

3. Comparison of fluorescent ROS probes (DCFDA, MitoSOX, DHE)

4. Antioxidant enzyme activity assays (SOD, Catalase, GPx) in ROS regulation

5. ROS role in immune cell activation and T cell exhaustion

6. Oxidative stress in tumor microenvironment and immune suppression

01 Mitochondrial ROS production and electron transport chain dysfunction

Mitochondria are the primary source of mitochondrial ROS, with the electron transport chain (ETC) generating superoxide (O₂•⁻). Electrons leaking from Complexes I and III reduce oxygen to O₂•⁻^[1,2]. Complex I generates O₂•⁻ at the FMN cofactor and ubiquinone site, while Complex III produces it at the Qₒ site via ubisemiquinone intermediates^[1,2]. Beyond canonical forward electron flow, Complex II (succinate dehydrogenase) can also contribute to ROS generation under specific conditions, such as when succinate accumulates or the Q pool is highly reduced. The structural arrangement of ETC components into supercomplexes modulates this process; while supercomplex formation generally limits electron leak by substrate channeling, certain pathological disassembly events can expose catalytic sites to oxygen, exacerbating O₂•⁻ production.

Reverse electron transport (RET), occurring under highly reduced ubiquinol pools and elevated protonmotive force, drives substantial O₂•⁻ production. RET is implicated in ischemia-reperfusion injury and hypoxic sensing. The active/deactive (A/D) transition of Complex I during hypoxia also modulates ROS output^[2]. Mitochondrial ROS (specifically H₂O₂) regulate hypoxic adaptation, apoptosis, and differentiation via glutathione and thioredoxin systems dependent on NNT-generated NADPH^[1]. Furthermore, mitochondrial dynamics, including fusion and fission events, influence ROS emission; fragmented mitochondria often exhibit higher ROS leak due to impaired ETC efficiency and reduced membrane potential. The interplay between mitochondrial morphology and ETC dysfunction represents a critical feedback loop in oxidative stress pathologies^[1,2].

Fig. 1 Hela cells were cultured with or without (Control) 5 μM Antimycin A for 1 h, and then changes in mitochondrial ROS were detected by mitochondrial superoxide fluorometric assay kit. (The data are provided by Elabscience)

02 Fluorescent probe-based detection of intracellular ROS (DCFDA assay)

The reactive oxygen species assay remains fundamental to oxidative stress research. Among ROS detection methods, the 2', 7'-dichlorodihydrofluorescein diacetate (DCFDA) ROS assay is prevalent. DCFDA passively diffuses into cells, where esterases cleave acetate groups to form DCFH. Subsequent oxidation by intracellular ROS yields fluorescent DCF, detectable by spectrofluorometry or ROS assay flow cytometry^[3,4].

Despite four decades of use, the DCFDA oxidative stress assay faces limitations. DCFH oxidation occurs via hydroxyl radicals, peroxynitrite, and hydrogen peroxide (in the presence of peroxidases), lacking specificity for a single ROS species. Auto-oxidation, photo-oxidation, and interference from cytochrome c release during apoptosis further confound results^[3]. Glutathione competes for ROS, potentially causing underestimation. Figueroa et al. optimized real-time monitoring in MCF-7 cells, establishing 10–25 μM DCFDA with 45-min incubation as ideal for sensitivity without cytotoxicity^[5]. However, Tarpey and Fridovich caution that this ROS assay serves best as a qualitative marker of oxidant stress rather than a precise quantifier of specific ROS production rates^[3].

Fig. 2 HepG2 cells were treated with or without Erastin for 24 h, and then changes in ROS were detected by reactive oxygen species fluorometric assay kit. (The data are provided by Elabscience)

03 Comparison of fluorescent ROS probes (DCFDA, MitoSOX, DHE)

Selecting appropriate ROS detection methods is critical for accurate oxidative stress assessment.

DCFDA, a cell-permeable non-fluorescent dye, is oxidized by ROS such as H₂O₂, hydroxyl radicals, and peroxynitrite in a peroxidase-dependent manner to produce the fluorescent dichlorofluorescein (DCF). While widely used due to its sensitivity, DCFDA exhibits broad-spectrum reactivity and significant redox cycling artifacts, which can lead to overestimation of ROS levels. Furthermore, its diffuse cellular distribution complicates efforts to pinpoint specific organelle sources.

Dihydroethidium (DHE) is primarily utilized for detecting superoxide (O₂•⁻). Upon oxidation, DHE forms ethidium (E⁺), which intercalates into DNA, as well as the superoxide-specific product 2-hydroxyethidium (2-OH-E⁺). However, distinguishing 2-OH-E⁺ from the non-specific ethidium signal requires high-performance liquid chromatography (HPLC), limiting its utility for routine ROS assay flow cytometry.

MitoSOX Red, a triphenylphosphonium-conjugated DHE derivative, targets mitochondria via ΔΨm-driven accumulation. Specific detection of mitochondrial O₂•⁻ typically requires HPLC to bypass spectral overlap and auto-oxidation artifacts inherent to standard fluorescence microscopy^[6]. Excessive probe concentrations risk impairing mitochondrial function, while photo-oxidation remains a significant limitation during prolonged imaging^[6].

Optimizing probe loading is critical for accurate ROS detection methods. Strict control of DMSO solvent concentration (<0.1% v/v) is necessary to prevent cytotoxicity or protein denaturation. Researchers must account for probe autofluorescence, particularly with MitoSOX, which elevates background noise and masks weak signals in low-ROS settings. Consequently, validating assay specificity through pharmacological inhibition or scavenger controls, alongside employing multiple independent detection techniques, is essential to mitigate these technical variables^[4].

04 Antioxidant Enzyme Activity Assays (SOD, Catalase, GPx) in ROS Regulation

Cellular antioxidant defenses are quantified through specific enzymatic tests that are central to any oxidative stress assay. The SOD activity assay utilizes a xanthine/xanthine oxidase system to generate O₂•⁻, which reduces WST-1. SOD competes for this substrate, and the percent inhibition of reduction directly correlates with activity^[7]. The catalase activity assay measures the decomposition of H₂O₂ into water and oxygen; residual H₂O₂ is reacted with ammonium molybdate to form a stable yellow complex, with activity quantified by absorbance at 405 nm. The glutathione peroxidase assay kit assesses total GSH-Px activity by monitoring the reduction of H₂O₂ by GSH to form GSSG. As GSH reacts non-enzymatically with H₂O₂, this background rate is subtracted. Specific activity is determined by quantifying remaining GSH via its reaction with dinitrobenzoic acid at 412 nm^[7].

Methodological rigor requires careful sample handling; homogenization in ice-cold protease inhibitor buffers preserves labile enzymes like MnSOD. Ensuring saturating concentrations of cofactors (e.g., GSH, NADPH) prevents rate-limiting artifacts. Normalizing enzyme velocities to total protein content and incorporating internal standards controls for inter-assay variability, ensuring that data reflect true physiological redox adaptations rather than extraction inefficiencies^[7].

Fig. 3 Antioxidant enzyme activities (SOD, GPX, and CAT) measured in different sample types by total superoxide dismutase (T-SOD) activity assay kit, glutathione peroxidase activity assay kit and catalase(CAT) activity assay kit. (The data are provided by Elabscience)

05 ROS role in immune cell activation and T cell exhaustion

ROS exert dual effects in T cell biology, acting as second messengers for activation while promoting T cell exhaustion at excess levels. Post-TCR engagement, mitochondrial ROS are essential for NFAT activation and IL-2 production. Complex III-derived ROS support metabolic reprogramming for clonal expansion^[8].

Moderate ROS levels facilitate activation via reversible oxidation of phosphatases (e.g., SHP-1/2), enhancing TCR signaling and activating PI3K/Akt/mTORC1-driven glycolysis. MYC induction is ROS-dependent, and glutathione scavenging defines a permissive window for NFAT/mTOR activation^[8]. Conversely, the tumor microenvironment (TME) imposes chronic oxidative stress. Tumor-infiltrating lymphocytes exhibit mitochondrial dysfunction and increased apoptosis sensitivity^[9,10]. Excessive ROS downregulate TCR ζ-chain, impair NF-κB, and reduce IFN-γ or TNF-α production^[10]. MDSCs and TAMs suppress T cell function via ROS, while Tregs endure the TME due to superior antioxidant capacity^[9,10]. Yang et al. noted ROS influence M1/M2 polarization and dendritic cell antigen presentation, with excess ROS causing ER stress^[9,11].

06 Oxidative stress in tumor microenvironment and immune suppression

The TME exhibits elevated ROS from cancer cell metabolism and immune infiltrates. Cancer cells upregulate NRF2/KEAP1 and glutathione synthesis to survive, creating a therapeutic vulnerability to further ROS elevation^[10]. MDSCs utilize ROS to suppress T cells via TCR/MHC inhibition, amino acid depletion, peroxynitrite cytotoxicity, and COX-2 upregulation^[9,10]. ROS modify antigen peptide cysteine residues, altering TCR affinity, and modulate PD-L1 expression^[9]. Kotsafti et al. highlighted NOX2-dependent ROS in maintaining MDSC immunosuppression. Aboelella et al. described exploiting TME oxidative stress via immunotherapy; TNFα and IFNγ disrupt redox homeostasis, depleting glutathione and driving ferroptosis. Combining pro-oxidants with immune checkpoint blockade synergistically suppresses tumors^[10].

Metabolic competition within the TME further exacerbates oxidative stress. Cancer cells often exhibit the Warburg effect, consuming large amounts of glucose and secreting lactate, which acidifies the extracellular milieu and impairs T cell glycolytic flux. This nutrient starvation forces T cells into a catabolic state, increasing mitochondrial ROS production and promoting senescence. Furthermore, lipid peroxidation products derived from oxidative stress in the TME can act as endogenous ligands for pattern recognition receptors on dendritic cells, modulating inflammatory cytokine secretion. The interplay between ROS and the kynurenine pathway, upregulated by IDO expression in tumor cells, creates a feedback loop where tryptophan metabolites further induce ROS production in effector T cells, reinforcing the immunosuppressive niche. Targeting these metabolic checkpoints alongside redox modulation presents a promising avenue for restoring T cell effector function in solid tumors^[9,10].

Elabscience^® Quick Overview of Popular Products:

Table 1. Reagents for oxidative stress

References:

[1] Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biology. 2020;37:101674

[2] Hernansanz-Agustín P, Enríquez JA. Generation of reactive oxygen species by mitochondria. Antioxidants. 2021;10(3):415

[3] Chen X, Zhong Z, Xu Z, Chen L, Wang Y. 2′,7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radical Research. 2010;44(6):587–604

[4] Yazdani M. Concerns in the application of fluorescent probes DCDHF-DA, DHR 123 and DHE to measure reactive oxygen species in vitro. Toxicology in Vitro. 2015;30(1):578–582

[5] Figueroa D, Asaduzzaman M, Young F. Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2′,7′–dichlorodihydrofluorescin diacetate (DCFDA) assay. Journal of Pharmacological and Toxicological Methods. 2018;94:26–33

[6] Zhang X, Gao F. Imaging mitochondrial reactive oxygen species with fluorescent probes: Current applications and challenges. Free Radical Research. 2015;49(4):374–382

[7] Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature Protocols. 2009;5(1):51–66

[8] Franchina DG, Dostert C, Brenner D. Reactive oxygen species: Involvement in T cell signaling and metabolism. Trends in Immunology. 2018;39(6):489–502

[9] Kotsafti A, Scarpa M, Castagliuolo I, Scarpa M. Reactive oxygen species and antitumor immunity—From surveillance to evasion. Cancers. 2020;12(7):1748

[10] Aboelella NS, Brandle C, Kim T, Ding ZC, Zhou G. Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy. Cancers. 2021;13(5):986

[11] Yang Z, Min Z, Yu B. Reactive oxygen species and immune regulation. International Reviews of Immunology. 2020;39(6):292–298